[go: up one dir, main page]

NO20072893L - Fast, peroralt prevensjonsmiddel - Google Patents

Fast, peroralt prevensjonsmiddel

Info

Publication number
NO20072893L
NO20072893L NO20072893A NO20072893A NO20072893L NO 20072893 L NO20072893 L NO 20072893L NO 20072893 A NO20072893 A NO 20072893A NO 20072893 A NO20072893 A NO 20072893A NO 20072893 L NO20072893 L NO 20072893L
Authority
NO
Norway
Prior art keywords
dienogest
ethinyl estradiol
solid oral
released
active component
Prior art date
Application number
NO20072893A
Other languages
English (en)
Inventor
Hagen Gerecke
Sabine Fricke
Ralf Ladwig
Alexander Buske
Harald Rathe
Original Assignee
Bayer Schering Pharma Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from EP05003181A external-priority patent/EP1690529A1/de
Priority claimed from EP05003179A external-priority patent/EP1690543A1/de
Application filed by Bayer Schering Pharma Ag filed Critical Bayer Schering Pharma Ag
Publication of NO20072893L publication Critical patent/NO20072893L/no

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2072—Pills, tablets, discs, rods characterised by shape, structure or size; Tablets with holes, special break lines or identification marks; Partially coated tablets; Disintegrating flat shaped forms
    • A61K9/2077—Tablets comprising drug-containing microparticles in a substantial amount of supporting matrix; Multiparticulate tablets
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A61K31/565—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids not substituted in position 17 beta by a carbon atom, e.g. estrane, estradiol
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A61K31/565—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids not substituted in position 17 beta by a carbon atom, e.g. estrane, estradiol
    • A61K31/567—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids not substituted in position 17 beta by a carbon atom, e.g. estrane, estradiol substituted in position 17 alpha, e.g. mestranol, norethandrolone
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A61K31/57—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane or progesterone
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2072—Pills, tablets, discs, rods characterised by shape, structure or size; Tablets with holes, special break lines or identification marks; Partially coated tablets; Disintegrating flat shaped forms
    • A61K9/2086—Layered tablets, e.g. bilayer tablets; Tablets of the type inert core-active coat
    • A61K9/209—Layered tablets, e.g. bilayer tablets; Tablets of the type inert core-active coat containing drug in at least two layers or in the core and in at least one outer layer
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/28—Dragees; Coated pills or tablets, e.g. with film or compression coating
    • A61K9/2806—Coating materials
    • A61K9/2833—Organic macromolecular compounds
    • A61K9/286—Polysaccharides, e.g. gums; Cyclodextrin
    • A61K9/2866—Cellulose; Cellulose derivatives, e.g. hydroxypropyl methylcellulose
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A61P15/18—Feminine contraceptives

Landscapes

  • Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Epidemiology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Gynecology & Obstetrics (AREA)
  • Organic Chemistry (AREA)
  • Reproductive Health (AREA)
  • Endocrinology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Orthopedics, Nursing, And Contraception (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Steroid Compounds (AREA)

Abstract

Tilkjennegjort blir et fast, peroralt prevensjonslegemiddel som inneholder 17-a-cyanometyl-17-ß-hydroksyøstra-4,9-dien-3-on (dienogest) med en daglig dose som er lik eller mindre enn 2,0 mg som en aktiv komponent og 17-a-etinyløstradiol (etinyløstradiol) som en daglig dose på mindre enn 0,03 mg som en annen, aktiv komponent, sammen med én eller flere farmasøytisk akseptable bærere. Dienogest blir proporsjonelt frigjort i minst to faser, mens etinyløstradiol blir frigjort samtidig som den første fasen med dienogest.
NO20072893A 2005-02-15 2007-06-06 Fast, peroralt prevensjonsmiddel NO20072893L (no)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
EP05003181A EP1690529A1 (de) 2005-02-15 2005-02-15 Feste perorale Arzneiform zur Kontrazeption, die Dienogest und Ethinylestradiol enthält
EP05003179A EP1690543A1 (de) 2005-02-15 2005-02-15 Pharmazeutisches Präparat zur Kontrazeption
PCT/EP2006/001358 WO2006087177A2 (de) 2005-02-15 2006-02-15 Feste perorale arzneiform zur kontrazeption, die dienogest und ethinylestradiol enthält

Publications (1)

Publication Number Publication Date
NO20072893L true NO20072893L (no) 2007-09-12

Family

ID=37951746

Family Applications (1)

Application Number Title Priority Date Filing Date
NO20072893A NO20072893L (no) 2005-02-15 2007-06-06 Fast, peroralt prevensjonsmiddel

Country Status (20)

Country Link
EP (1) EP1848406B1 (no)
JP (1) JP2008527019A (no)
KR (1) KR20070087141A (no)
AT (1) ATE395047T1 (no)
AU (1) AU2006215822B2 (no)
BR (1) BRPI0606297A2 (no)
CA (1) CA2594939A1 (no)
CY (1) CY1108265T1 (no)
DE (1) DE502006000771D1 (no)
DK (1) DK1848406T3 (no)
EA (1) EA200701389A1 (no)
ES (1) ES2310907T3 (no)
HR (1) HRP20080394T3 (no)
IL (1) IL184257A0 (no)
NO (1) NO20072893L (no)
PL (1) PL1848406T3 (no)
PT (1) PT1848406E (no)
RS (1) RS50597B (no)
SI (1) SI1848406T1 (no)
WO (1) WO2006087177A2 (no)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP2170347A1 (de) * 2007-07-31 2010-04-07 Bayer Schering Pharma Aktiengesellschaft Einphasisches pharmazeutisches kombinationspräparat (dienogest und ethinylestradiol) zur oralen therapie der regulierung des blutdruckes
JP2010529063A (ja) * 2007-07-31 2010-08-26 バイエル・シエーリング・ファーマ アクチエンゲゼルシャフト 血圧の調節のための経口治療のための、単相医薬複合調製物（ジエノゲスト（ｄｉｅｎｏｇｅｓｔ）およびエチニルエストラジオール）
JP6759478B2 (ja) * 2019-02-13 2020-09-23 富士製薬工業株式会社 経口固形組成物、その製造方法、及びその製造方法によって得られた経口用錠剤
EP3954364A1 (en) 2020-08-14 2022-02-16 Chemo Research, S.L. New modified release oral contraceptive composition
KR102652671B1 (ko) 2023-12-26 2024-03-29 주식회사 스몰랩 피임 마이크로니들용 미립구 조성물 및 이를 포함한 피임 마이크로니들

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE19525017A1 (de) * 1995-06-28 1997-01-02 Schering Ag Pharmazeutisches Kombinatonspräparat, Kit und Methode zur hormonalen Kontrazeption
EP0956024B1 (en) * 1996-07-26 2004-07-21 Wyeth Monophasic oral contraceptive method and kit comprising a combination of progestin and estrogen

Also Published As

Publication number Publication date
DE502006000771D1 (de) 2008-06-26
AU2006215822B2 (en) 2008-09-04
CA2594939A1 (en) 2006-08-24
JP2008527019A (ja) 2008-07-24
CY1108265T1 (el) 2014-02-12
WO2006087177A2 (de) 2006-08-24
PL1848406T3 (pl) 2009-06-30
PT1848406E (pt) 2008-08-21
EP1848406B1 (de) 2008-05-14
EP1848406A2 (de) 2007-10-31
DK1848406T3 (da) 2008-09-15
EA200701389A1 (ru) 2008-02-28
ATE395047T1 (de) 2008-05-15
SI1848406T1 (sl) 2008-10-31
RS50597B (sr) 2010-05-07
IL184257A0 (en) 2007-10-31
WO2006087177A8 (de) 2007-05-24
HRP20080394T3 (hr) 2008-11-30
BRPI0606297A2 (pt) 2009-06-09
ES2310907T3 (es) 2009-01-16
WO2006087177A3 (de) 2007-08-30
AU2006215822A1 (en) 2006-08-24
KR20070087141A (ko) 2007-08-27
WO2006087177B1 (de) 2007-10-11

Similar Documents

Publication Publication Date Title
EA200900491A1 (ru) Применение эстрадиола валерата или 17в-эстрадиола в комбинации с диеногестом для перорального лечения для поддержания и/или повышения полового влечения у особи женского пола
HRP20070188B1 (hr) Farmaceutska kombinacija etinilestradiola i drospirenona za upotrebu kao kontracepcijskog sredstva
HRP20090418T1 (hr) Farmaceutski pripravak koji sadrži gestagene i/ili estrogene i 5-metil-(6s)-tetrahidrofolate
NO327588B1 (no) Farmasoytisk sammensetning og preparat omfattende etinylostradiol og drospirenon for anvendelse som antikonsepsjonsmiddel
NO20072893L (no) Fast, peroralt prevensjonsmiddel
AR049197A1 (es) Anticonceptivo hormonal conteniendo una combinacion de etinilestradiol y acetato de clormadinona
HRP20100513T1 (hr) Višefazni kontracepcijski pripravak zasnovan na prirodnom estrogenu
TW200638951A (en) Solid oral pharmaceutical form for contraception
UA85003C2 (ru) Твердая лекарственная форма для контрацепции
EA200900829A1 (ru) Фармацевтический препарат для уменьшения эндометриоза
WO2008017331A3 (de) Perorale arzneiform mit dienogest und ethinylestradiol zur kontrazeption
TW200731977A (en) Use of estradiol valerate in combination with dienogest for the oral treatment of dysfunctional uterine bleeding in conjunction with oral contraception
TH80558A (th) รูปแบบยาทางช่องปากชนิดแข็งสำหรับการคุมกำเนิด
CY1112775T1 (el) Χρηση βαλεριανικης οιστραδιολης σε συνδυασμο με dienogest για την απο του στοματος θεραπεια της δυσλειτουργικης αιμορραγιας της μητρας σε ενοτητα με αντισυλληψη απο του στοματος
UY29378A1 (es) Preparación farmaceutica para la anticoncepción oral
PE20091020A1 (es) Uso de un gestageno en combinacion con un estrogeno y uno o varios excipientes/portadores farmaceuticamente aceptables para la anticoncepcion oral sin lactosa
RU2009140372A (ru) Новый режим с дроспиреноном/17b-эстрадиолом, фармацевтический комбинированный продукт и набор для выполнения этого режима
UA4315U (uk) Спосіб лікування системного червоного вовчака
JO2213B1 (en) A pharmaceutical composition for use as a contraceptive method

Legal Events

Date Code Title Description
FC2A Withdrawal, rejection or dismissal of laid open patent application